Cardiovascular Disorder (1)

Embed Size (px)

Citation preview

  • 8/4/2019 Cardiovascular Disorder (1)

    1/59

    Cardiovascular Disorder (1)

  • 8/4/2019 Cardiovascular Disorder (1)

    2/59

    http://images.google.com/imgres?imgurl=http://www.plantcon.dk/img/car.jpg&imgrefurl=http://www.plantcon.dk/uk/freedown.htm&h=249&w=397&sz=9&tbnid=FIcjRkb0tV8J:&tbnh=75&tbnw=119&start=16&prev=/images%3Fq%3Dcar%26hl%3Den%26lr%3D%26ie%3DUTF-8%26sa%3DG
  • 8/4/2019 Cardiovascular Disorder (1)

    3/59

    Outlines

    ArteriosclerosisHypertension

    SyncopeShockHeart Failure

    Cor Pulmonale

  • 8/4/2019 Cardiovascular Disorder (1)

    4/59

    Arteriosclerosis; Atherosclerosis

    Definition:Subintimal thickening of medium andlarge arteries

    Pathology and pathogenesisfatty streak is evolved into fibrousplaque

    fibrous plaque - smooth m. cells,connective tissues, intra and extra-cellular lipids

  • 8/4/2019 Cardiovascular Disorder (1)

    5/59

  • 8/4/2019 Cardiovascular Disorder (1)

    6/59

    Cardiovascular risk factorsRiskFactors of Atherosclerosis

    A. modified:DyslipidemiasHypertensionDiabetes MellitusCigarette SmokingObesity (BMI>30)Physical inactivity

    Chobanian AV et al. The 7th Report of the Joint National Committee on Prevention, Detection,Evaluaation, and Treatment of High Blood Pressure. JAMA 2003:289:2560

  • 8/4/2019 Cardiovascular Disorder (1)

    7/59

    B. unmodified:Age: >55 for men, >65 for womenMale gender

    Increased risk in menIncreased risk in women aftermenopause

    Family history of prematurecardiovascular diseaseMen

  • 8/4/2019 Cardiovascular Disorder (1)

    8/59

    Risk Factors of Atherosclerosis

    Risk factors (emerging)HomocystinemiaClamydial pneumonia infection

  • 8/4/2019 Cardiovascular Disorder (1)

    9/59

    Atherosclerosis

    Symptoms/ SignsPatients are asymptomatic untilcomplications developComplications: critical stenosis, thrombosis,aneurysm, embolism)

    In brain: TIA, strokeIn heart: angina pectoris, M.I.In low extremities: intermittent claudication

    DiagnosisObstruction can be confirmed by Dopplerultrasonography

    Doppler ultrasonography : a tech which monitorsthe moving substance eg. flowing blood, beatingheart

  • 8/4/2019 Cardiovascular Disorder (1)

    10/59

    Atherosclerosis

    Prevention: prevent risk factorsTreatment

    directed at its complicationsshould be aggressive for patientswith established atherosclerosis

  • 8/4/2019 Cardiovascular Disorder (1)

    11/59

    *Treatment

    Lifestyle changes (diet, smoking, physical activity)Diet:

    Less saturated fatNo trans fatsMore fruits and vegetablesMore fiberModerate (if any) alcohol

    Regular physical activity (eg, 30 to 45 min of walking,running, swimming, or cycling 3 to 5 times/wk)

    Drug treatment of diagnosed risk factorsAntiplatelet drugsPossibly statins, ACE inhibitors, -blockers

  • 8/4/2019 Cardiovascular Disorder (1)

    12/59

    Hypertension

  • 8/4/2019 Cardiovascular Disorder (1)

    13/59

    *Hypertension-Epidemiology

    In the US, about 65 million people havehypertension.Only about 70% of these people are

    aware that they have hypertension, only59% are being treated, and only 34%have adequately controlled BP.In adults, hypertension occurs more

    often in blacks (32%) than in whites(23%) or Mexican Americans (23%), andmorbidity and mortality are greater inblacks.

  • 8/4/2019 Cardiovascular Disorder (1)

    14/59

    Systemic Hypertension

    DefinitionHypertension: chronic elevation of BP:> 140/90 mmHg(Isolated) Systolic Hypertension:

    systolic BP> 160, diastolic BP< 90

  • 8/4/2019 Cardiovascular Disorder (1)

    15/59

    Classification Systolicpressure

    Diastolicpressure

    Normal

  • 8/4/2019 Cardiovascular Disorder (1)

    16/59

    Hypertension Physiology:

    Physiologic determinants ofarterial pressure:( BP= CO x TPR)

    cardiac output (C.O.)total peripheral resistance (TPR):viscosity, radius of artery, hemotocrit

    arterial blood volumeelasticity of aorta (compliance)

  • 8/4/2019 Cardiovascular Disorder (1)

    17/59

    Hemodynamics of bloodpressure

    Sympathetic hyperactivityesp. in youngTachycardia & increased CO

    Renin - Angiotensin-Aldosteronesystem (RAS system) PG I2( prostaglandin) & TX A2( thromboxan): vasodilatation &vasoconstriction

  • 8/4/2019 Cardiovascular Disorder (1)

    18/59

  • 8/4/2019 Cardiovascular Disorder (1)

    19/59

    Pathology

    The target organs of hypertension:Heart:

    LVH,CAD

    Brain:cerebrovascular disease, hypertensiveencephalopathy

    Eye (retina):arteriosclerosis, exudates, hemorrhage,papilladema

    Kidney:renal arteriosclerosis, renal function impairment

  • 8/4/2019 Cardiovascular Disorder (1)

    20/59

    *Etiology & ClassificationPrimary Hypertension (EssentialHypertension):

    85 to 95% of cases Unknown etiology*Between ages 25-55 yearsHeredity is a predisposing factor

    Environmental factors (eg, dietary Na,

    obesity, stress) seem to affect onlygenetically susceptible people.

    Multiple factors are probably involvedin sustaining elevated BP

  • 8/4/2019 Cardiovascular Disorder (1)

    21/59

    Secondary HypertensionRenal Artery StenosisCoarctation of AortaPheochromocytoma: catecholamine-producing tumorHyperaldosteronism: tumor or

    hyperplasia in zona glomerulosaOther Causes: oral contraceptiveusage, Cushings syndrome

  • 8/4/2019 Cardiovascular Disorder (1)

    22/59

  • 8/4/2019 Cardiovascular Disorder (1)

    23/59

    Coarctation of Aorta

    Aortic coarctation causes low bloodpressure and low blood flow in thearteries that branch off below the

    narrow spot; high blood pressure occurs in the arteries that branch offcloser to the heart. As a result, aorticcoarctation often leads to high bloodpressure in the upper body and arms(or one arm) and low blood pressurein the lower body and legs.

    http://www.nlm.nih.gov/medlineplus/ency/article/003083.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003083.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003082.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003082.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003083.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003083.htm
  • 8/4/2019 Cardiovascular Disorder (1)

    24/59

    Symptoms/ Signs

    Primary hypertension:Asymptomatic until complications intarget organs

    Severe hypertensionDizziness, flushed face, headache,fatigue, nervousness, blurred vision

    A h h i i h

  • 8/4/2019 Cardiovascular Disorder (1)

    25/59

    Approach to the patient withhypertension

    HistoryPhysical Examination: leg & armBPLaboratory work-up:

    BUN, Cr, CXR, renin, aldosterone

    Primary hypertension: repeatedlyelevated BPExclude secondary hypertension

  • 8/4/2019 Cardiovascular Disorder (1)

    26/59

    Treatment-Lifestyle modification

  • 8/4/2019 Cardiovascular Disorder (1)

    27/59

  • 8/4/2019 Cardiovascular Disorder (1)

    28/59

    Treatment-Drugs

    Antihypertensive drug therapy:systolic BP remains > 140 mm Hgor diastolic BP remains > 90 mmHg after 6 mo of lifestylemodifications, antihypertensivedrugs are required.

    See attachment

  • 8/4/2019 Cardiovascular Disorder (1)

    29/59

    *Malignant hypertension

    Severe hypertension with signs of damage to target organs (primarily the brain, cardiovascular system, and kidneys).Diastolic pressure>120mm-HgAssociated with encephalopathy or nephropathy withpapilledemaClinical manifestations

    BP is elevated, often markedly (diastolic > 120 mm Hg).CNS symptoms include rapidly changing neurologic

    abnormalities (eg, confusion, transient cortical blindness,hemiparesis, hemisensory defects, seizures).Cardiovascular symptoms include chest pain and dyspnea.Renal involvement may be asymptomatic, although severeazotemia due to advanced renal failure may producelethargy or nausea.

  • 8/4/2019 Cardiovascular Disorder (1)

    30/59

    *Malignant hypertension

    Diagnosis is by BP measurement, ECG,urinalysis, and serum BUN and creatinine measurements.Treatment is immediate BP reduction

    with IV drugs (eg, nitroprusside, - blockers, hydralazine). Hypertensive emergencies, requiring

    aggressive and immediate treatment.Damage is rapidly progressive and often fatal.

  • 8/4/2019 Cardiovascular Disorder (1)

    31/59

    *Malignant hypertension

    Diastolic pressure>120mm-HgAssociated with encephalopathy ornephropathy with papilledema

    Clinical manifestationsEncephalopathy:headache, seizure,

    Retinopathyvisual disturbance

    Deteriorating renal functionCardiac decomposition:

    CHF, angina

  • 8/4/2019 Cardiovascular Disorder (1)

    32/59

  • 8/4/2019 Cardiovascular Disorder (1)

    33/59

    Syncope (Fainting)

    Definition:transient loss of consciousness dueto reduced cerebral blood flow

  • 8/4/2019 Cardiovascular Disorder (1)

    34/59

    Causes of SyncopeI. Disorders of vascular tone orblood volume

    1.Vasovagal (vasodepressor)syncope

    Excessive vagal tonePrecipitated by unpleasant physical oremotional stimuliPreceded by vagal activity: nausea,yawning, visual blurring, weakness,sweatingOccur in upright; e.g. fainting to needling

  • 8/4/2019 Cardiovascular Disorder (1)

    35/59

    I. Disorders of vascular tone orblood volume (cont.)

    2.Postural (orthostatic) hypotensionCaused by hypovolemic or venous poolingOccurs while standing up suddenly

    E.g. UGI bleeding, ectopic pregnancy rupture

    E.g. after prolonged bed rest or severe varicosevein

    E.g. standing without moving in healthy person

    3.Carotid sinus hypersensitivityRubbing carotid sinus, causing elevated BP incarotid sinus, resulting in reduced HR & slow AVconduction

  • 8/4/2019 Cardiovascular Disorder (1)

    36/59

  • 8/4/2019 Cardiovascular Disorder (1)

    37/59

    Approach to the patient withsyncope

    History:the position of patient at time ofsyncope, in particular situation

    Laboratory findings:blood sugar, ECG, echocardiogram,hematocrit

  • 8/4/2019 Cardiovascular Disorder (1)

    38/59

    Treatment

    Postural hypotension & vasovagalsyncope: horizontal postureTreat underlying causes:

    Vasovagal syncope: avoid situationOrthostatic hypotension: rise slowlyVolume depletion:Bradyarrhythmia: pacemaker

  • 8/4/2019 Cardiovascular Disorder (1)

    39/59

    Prognosis

    Depends on causes

  • 8/4/2019 Cardiovascular Disorder (1)

    40/59

    ShockDefinition:a state of inadequate blood flow orperfusion of peripheral tissues tosustain life

    Resulting from:Inadequate C.O. or misdistribution ofperipheral blood flow , associatedwith hypotension and oliguria

  • 8/4/2019 Cardiovascular Disorder (1)

    41/59

    Classification of shockHypovolemic shock:

    HemorrhageVolume depletionInternal sequestration: the blood fromsystemic circulation to a non-functional area

    Cardiogenic shock:

    MyopathicArrhythmic

  • 8/4/2019 Cardiovascular Disorder (1)

    42/59

    Classification of shock (cont.)

    Extracardiac obstructive shock:Pericardial tamponadeTension pneumothorax

    Vasodilatory shock: relativelyinadequate intravascular volume(vasodilation)

    SepsisAnaphylaxis ( systemic vasodilatation)

  • 8/4/2019 Cardiovascular Disorder (1)

    43/59

  • 8/4/2019 Cardiovascular Disorder (1)

    44/59

    Symptoms/ Signs of Shock

    Mentation:letharge, confusion, somnolence

    Hands & feet: cold, moist, cyanotic, pale

    Pulse: weak, rapid ( unless terminalbradycardia)Breathing: tachypnea, hyperventilation( apnea in terminal )B.P.:

  • 8/4/2019 Cardiovascular Disorder (1)

    45/59

    Hyperdynamic syndrome

    A cluster of S/S which signals theonset of septic shock ( early stageof septic shock)Characterized by shaking chills,rapid rise in temperature, flushingof skin, gallop pulse, alternatingrise & fall B.P.

  • 8/4/2019 Cardiovascular Disorder (1)

    46/59

    Treatment of ShockFirst Aid:

    Keep warm, leg raisedStop hemorrhage

    Supportive treatmentDopamine or norepinephrine

    O2Carefully monitorTreat underlying causes:

    Hypovolemic shock: restore intravascular

    volumeVasodilatory shock: fluid resuscitation withnormal saline, vasopressor drugs,antibioticsCardiogenic shock: improving cardiacperformance

  • 8/4/2019 Cardiovascular Disorder (1)

    47/59

    Prognosis of Shock

    Depending on the causeUntreated shock: fatalCardiogenic shock due to M.I.,septic shock: high mortality

  • 8/4/2019 Cardiovascular Disorder (1)

    48/59

  • 8/4/2019 Cardiovascular Disorder (1)

    49/59

    The Heart

    www.youtube.com/watch?v=D3ZDJgFDdk0&feature=related

    http://www.youtube.com/watch?v=D3ZDJgFDdk0&feature=relatedhttp://www.youtube.com/watch?v=D3ZDJgFDdk0&feature=relatedhttp://www.youtube.com/watch?v=D3ZDJgFDdk0&feature=relatedhttp://www.youtube.com/watch?v=D3ZDJgFDdk0&feature=related
  • 8/4/2019 Cardiovascular Disorder (1)

    50/59

    Congestive Heart Failure

    Definition:a condition that the heart is unable to pumpsufficient blood for metabolizing tissues

    The heart is unable to perform its functionPhysiology

    Preload: end-diastolic volume ( venous return)Afterload: the load to resist ventricularcontraction

    l

  • 8/4/2019 Cardiovascular Disorder (1)

    51/59

    Heart Failure-Prevalence

    Both the incidence and prevalence of heartfailure increase with the ageIncidence:

    Over 65 years, incidence is 11/1,000 men peryear and 5/1,000 women per year

    Prevalence:Over 65 years, prevalence is 40/1,000 men and30/1,000 women

    ( Cowie MR et al. The epidemioology of heart failure. Eur Heart J 1997;18:208-225)

    Classification and Etiology of

  • 8/4/2019 Cardiovascular Disorder (1)

    52/59

    Classification and Etiology ofCongestive Failure

    Left ventricularfailure

    Coronary arterydiseaseHypertensionCardiomyopathyCongenital heartdisease

    Right ventricularfailure

    Prior LV failure:pulmonary vein pr.,

    pulmonary ahypertensionVolume overload: eg.over-transfusion,polycythemia

    F i l Cl ifi i f H

  • 8/4/2019 Cardiovascular Disorder (1)

    53/59

    Functional Classification of HeartDisease

    Class INo limitation of physical activity. Ordinary physicalactivity does not cause undue fatigue, dyspnea, oranginal pain

    Class II:Slight limitation of physical activity. Ordinary physicalactivity results in symptoms

    Class IIIMarked limitation of physical activity. Comfortable at rest,but less than ordinary activity causes symptoms

    Class IVUnable to engage in any physical activity withoutdiscomfort. Symptoms may be present even at rest

    New York Heart Association

    S / Si

  • 8/4/2019 Cardiovascular Disorder (1)

    54/59

    Symptoms/ Signsof Congestive Heart Failure

    LV failure:Fatigue on exertionDyspnea

    Intolerance to coldPulmonary rales

    RV failure:

    Fullness in neck (jugular veindistention)Hepatomegaly,Peripheral edema

  • 8/4/2019 Cardiovascular Disorder (1)

    55/59

    Acute pulmonary edema

    Life threateningAcute LV failure acute pulmonaryv. hypertensionS/S:

    extreme dyspneadeep cyanosistachypnea

  • 8/4/2019 Cardiovascular Disorder (1)

    56/59

    Laboratory findings

    EKG: LV hypertrophy, QRS wavedeeper & tallerCXR: cardiomegalyEchocardiography

    T f C i H

  • 8/4/2019 Cardiovascular Disorder (1)

    57/59

    Treatment of Congestive HeartFailure

    1.Decrease cardiac workload:decrease physical activity

    2.Control excess fluid retention:Dietary Na restrictionDiuretics

    Other medicationsVasodilatorsDigoxinACE inhibitors

    Refractory HF: heart transplantation

  • 8/4/2019 Cardiovascular Disorder (1)

    58/59

    Symptom relief: diuretics, nitrates,digoxinLong-term management, improvedsurvival:

    ACE inhibitors, -blockers, aldosteronereceptor blockers, angiotensin II receptor

    blockers (ARBs)

  • 8/4/2019 Cardiovascular Disorder (1)

    59/59